Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,396,524
-$418,869 QoQ
Shares Held
26,884
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#679
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names. GILD ranks #10 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,396,524 | 26,884 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,815,393 | 27,376 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,313,120 | 26,993 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,014,760 | 27,160 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,109,127 | 28,043 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,263,232 | 29,123 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,871,591 | 63,566 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $5,938,051 | 70,826 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,025,545 | 73,248 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5,674,824 | 77,472 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $8,435,166 | 104,125 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $8,254,715 | 110,151 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $5,176,946 | 67,172 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $5,540,072 | 66,772 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $5,641,117 | 65,709 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $3,874,502 | 62,806 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $3,784,008 | 61,220 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $3,478,954 | 58,519 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $3,965,449 | 54,613 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $3,596,995 | 51,496 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $3,146,282 | 45,691 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $2,736,951 | 42,348 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $2,436,141 | 41,815 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $2,625,228 | 41,545 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $3,240,789 | 42,121 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $3,091,400 | 41,351 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||